Bone Density Assessment When Using Aromatase Inhibitors
Cathy Cole, RNC, NP, MPH, CHES, CBPN-IC 9/29/2016 0
Postmenopausal women who find themselves diagnosed with estrogen-positive disease are often prescribed aromatase inhibitors (AI) for risk reduction. This classification of therapy ...
What Do You Know About Treatment-Induced Cardiotoxicity?
Katherine Mitchell, APRN, AOCNP 9/22/2016 10
As a young(er), semi-athletic female working in oncology, I often find myself especially unsettled when a fellow young female, newly diagnosed with breast cancer, ends up with ...
Marijke Vroomen Durning
Progress Made in Pediatric Cancer Research, But Long-Term Effects Still in Question
Marijke Vroomen Durning, RN 9/20/2016 0
Researchers have made great strides in the diagnosis and treatment of pediatric cancers over the past 5 decades, but there is still much to be done, according to a joint report ...
Deborah A. Boyle
Getting Ready for the Future: Improving Care for the Elderly With AML
Deborah A. Boyle, RN, MSN, AOCNS, FAAN 9/16/2016 0
The last 3 decades have demonstrated improvements in AML (acute myeloid leukemia) mostly in those under the age of 65 years.1 This unfortunately is not the case in elderly patients ...